Dr. Dennis Gross Donates $100,000 To Support Skin Cancer Research

Dr. Dennis Gross Skincare has pledged $100,000 to Memorial Sloan Kettering Cancer Center to support the exploration of new technologies for skin cancer detection.

Reflectance Confocal Microscopy Image (Viva block 8x8mm) at the dermal-epidermal level shows presence of widespread atypical melanocytes with follicular infiltration, non edged papillae and junctional thickened; these features will correspond to Melanoma Lentigo Maligna Type.
Reflectance Confocal Microscopy Image (Viva block 8x8mm) at the dermal-epidermal level shows presence of widespread atypical melanocytes with follicular infiltration, non edged papillae and junctional thickened; these features will correspond to Melanoma Lentigo Maligna Type.
Courtesy of Memorial Sloan Kettering Cancer Center

Dr. Dennis Gross Skincare has announced a $100,000 pledge to the Memorial Sloan Kettering Cancer Center (MSK).

The pledge will fund melanoma fellowships, with the goal of developing more effective strategies for detecting, preventing, controlling and, ultimately, curing skin cancer.

The donation supports a year-long research fellowship for Yuna Oh, a medical student at Weill Cornell Medicine. At MSK, she will focus her research efforts on expanding the clinical utility of reflectance confocal microscopy (RCM), a noninvasive imaging technology that captures in vivo photos and videos of the top skin layers in real time to help physicians and scientists noninvasively visualize whether a lesion is suspicious or not before excising skin.

"As an alumnus of MSK, I am honored to have the privilege to give back to the institution and support the critical research they are doing to develop skin cancer detection technology," said Dennis Gross, MD, board-certified dermatologist and co-founder of the namesake brand. "I am excited by RCM's potential to give key insights on the molecular makeup of melanomascientific breakthroughs that are going to save lives."

More in News